Sensei Biotherapeutics, Inc. (SNSE) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -10.73M | -3.86M | -3.59M | -5.91M | -7.09M | -5.79M | -5.47M | -5.79M | -7.62M | -6.16M | -4.66M | -9.46M | -11.74M | -9.57M | -6.8M | -11.9M | -10.75M | -7.87M | -5.58M | -6.05M |
| Operating CF Margin % | - | - | 73.92% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -51.3% | 33.29% | 34.44% | -2.02% | 6.85% | 6.02% | -17.36% | 38.79% | 35.11% | 35.63% | 31.49% | 20.47% | -9.17% | -21.68% | -21.98% | -96.78% | 0.16% | -193.58% | 3.81% | - |
| Net Income | -170.24M | -4.72M | -4.57M | -4.94M | -6.86M | -7.77M | -7.25M | -7.14M | -7.99M | -7.41M | -7.12M | -9.39M | -10.18M | -12.23M | -13.42M | -10.54M | -12.4M | -9.37M | -9.69M | -9.77M |
| Depreciation & Amortization | 30K | 34K | 34K | 37K | 34K | 331K | 332K | 0 | 331K | 135K | 332K | 491K | 358K | 469K | 342K | 320K | 448K | 329K | 136K | 122K |
| Stock-Based Compensation | 12.9M | 295K | 254K | 264K | 461K | 391K | 733K | 795K | 1.22M | 1.1M | 1.05M | 0 | 1.21M | 0 | 1.48M | 1.42M | 0 | 826K | 1.74M | 1.75M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 356K | -214K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 146.57M | 238K | 225K | 214K | 134K | 1.01M | 115K | 470K | 256K | 62K | 318K | 1.15M | 64K | 1.53M | 247K | 422K | 1.87M | 250K | -352K | 175K |
| Working Capital Changes | 0 | 286K | 469K | -1.49M | -859K | 250K | 603K | 85K | -1.43M | -400K | 979K | -1.72M | -3.19M | 655K | 4.54M | -3.52M | -667K | 93K | 2.59M | 1.68M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -104K | 0 | 0 | -1.22M | 1.11M | -427K | 0 | -354K | 306K | -781K | 471K | -2.26M | 242K | -184K | 2.23M | -2.68M | 2.64M | -1.02M | 740K | 732K |
| Cash from Investing | -31.44M | 2.08M | 1.74M | 8.76M | 7.19M | -3.15M | 12.91M | 6.91M | 5.77M | 8.26M | 8.31M | 19.53M | 2.31M | 16.04M | 8.52M | 13.2M | 12.19M | 5.61M | -482K | -147.76M |
| Capital Expenditures | -6K | 0 | 0 | -16K | 0 | 0 | 0 | -109K | -37K | 0 | 0 | -29K | -151K | 0 | -250K | -52K | -19K | -535K | -388K | -616K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 40K | -40K | 210K | 40K | 0 | 0 | 0 | 0 | -166K | 0 | 157K | 0 | 0 | 15K | -13.25K | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 6.46M | -40K | 40K | 0 | 0 | 0 | 0 | 0 | 0 | 166K | 0 | 0 | 9K | 0 | 8.77K | 13.25K | 0 | 0 | 318K | 0 |
| Cash from Financing | 185.83M | -111K | -152K | -168K | -214K | -194K | -204K | -180K | -209K | -431K | -2.53M | -7.95M | -262K | -124K | -163K | -119K | 119K | -118K | -7K | -11K |
| Debt Issued (Net) | 0 | -113K | -152K | -314K | -211K | -207K | -204K | -201K | -199K | -196K | -190K | -189K | -186K | -177K | -163K | -156K | -133K | -227K | -7K | -11K |
| Equity Issued (Net) | 200M | 2K | 0 | 5K | 0 | 34K | 0 | 0 | -10K | -204K | -2.34M | -7.79M | 0 | 104K | 0 | 0 | 238K | 1K | 0 | 23.49M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10K | -252K | -2.34M | -7.79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -14.17M | 0 | 0 | 141K | -3K | -21K | 0 | 21K | 0 | -31K | 0 | 31K | -76K | -51K | 0 | 37K | 14K | 108K | 0 | -23.49M |
| Net Change in Cash | 143.66M | -1.89M | -2M | 2.68M | -117K | -9.14M | 7.24M | 935K | -2.06M | 1.67M | 1.12M | 2.12M | -9.69M | 6.34M | 1.55M | 1.18M | 1.56M | -2.37M | -6.07M | -153.82M |
| Free Cash Flow | -10.74M | -3.86M | -3.59M | -5.92M | -7.09M | -5.79M | -5.47M | -5.9M | -7.65M | -6.16M | -4.66M | -9.49M | -11.89M | -9.57M | -7.05M | -11.95M | -10.77M | -8.4M | -5.96M | -6.66M |
| FCF Margin % | - | - | 73.92% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -51.38% | 33.29% | 34.44% | -0.41% | 7.3% | 6.02% | -17.36% | 37.83% | 35.62% | 35.63% | 33.91% | 20.58% | -10.38% | -13.94% | -18.24% | -79.36% | 4.31% | -180.47% | 10.08% | - |
| FCF per Share | -8.29 | -3.06 | -2.84 | -4.70 | -0.28 | -0.23 | -0.22 | -0.24 | -0.31 | -0.25 | -0.18 | -0.31 | -0.39 | -0.31 | -0.23 | -0.39 | -0.35 | -0.27 | -0.20 | -0.22 |
| FCF Conversion (FCF/Net Income) | 0.06x | 0.82x | 0.78x | 1.20x | 1.03x | 0.75x | 0.75x | 0.81x | 0.95x | 0.83x | 0.65x | 1.01x | 1.15x | 0.78x | 0.51x | 1.13x | 0.87x | 0.84x | 0.58x | 0.62x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 51K | 1K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |